SEC Filing Summary: Xenomics, Inc. (Form 8-K)
Business Context and Reporting Period
This Current Report (Form 8-K) was filed by Xenomics, Inc. on February 8, 2006. The report addresses a material accounting restatement regarding previously issued financial statements. The filing notes that the company's management and Audit Committee, in consultation with independent auditors Lazar Levine & Felix LLP, determined that unaudited quarterly financial statements for the periods ended July 31, 2005, and October 31, 2005, should no longer be relied upon.
Key Financial Metrics
The filing does not provide current revenue, profit, cash flow, or liquidity metrics. The only specific financial data disclosed relates to the restatement adjustments:
- Cumulative Expense Adjustment (6 months ended July 31, 2005): $598,137
- Cumulative Expense Adjustment (9 months ended October 31, 2005): $418,474
- Reason for Adjustment: Expenses associated with warrants issued during a financing transaction on July 13, 2005.
Material Changes Versus Prior Period
The primary material change is the restatement of historical financial data. The company amended its Form 10-QSB/A for the quarter ended July 31, 2005, and its Form 10-QSB for the quarter ended October 31, 2005, to reflect the additional warrant-related expenses. This action was taken following discussions with the SEC Staff regarding accounting comments on Amendment No. 2 to the Company's Form SB-2.
Guidance, Outlook, and Risks
The filing contains no forward-looking guidance, revenue outlook, or management commentary on future operations. The primary risk disclosed is the non-reliance on previously issued financial statements due to accounting errors related to warrant valuation. The company has completed the necessary amendments to its prior filings to correct these errors.
Key Facts for Investor Verification
- Verify the amended Form 10-QSB/A (July 31, 2005) and Form 10-QSB (October 31, 2005) to review the restated financial figures.
- Confirm the specific accounting treatment applied to the warrants issued on July 13, 2005, as detailed in the amended filings.
- Note that the registrant name in the filing header is Xenomics, Inc., despite the request metadata referencing Cardiff Oncology, Inc.
- Review the engagement of Lazar Levine & Felix LLP as the independent registered public accounting firm for the restatement.